The PFA product of Medtronic displayed on the NMPA official website---PulseSelectApproved for marketing, this is the first PFA product approved by NMPA that can be used for both paroxysmal atrial fibrillation and persistent atrial fibrillation.
As of now, the NMPA has approved four PFA products, which are PulsedFA by Jinjiang Electronics, CardiPulse by Denovo Electrophysiology, FARAPULSE by Boston Scientific, and Medtronic'sPulseSelect. These four products are very interesting, as the domestic and foreign products seem to be mirror images. PulsedFA andPulseSelectThe circular ablation catheter, CardiPulse, and FARAPULSE are petal-shaped ablation catheters. Although the products made in China and foreign products can correspond one-to-one, they still have various characteristics and advantages in design, which is why they can all go through the innovation channel.
However, Medtronic'sPulseSelectCompared with the other three products on the market, it has its own unique advantages. Its biggest advantage is that its indications are the most extensive, which gives Medtronic a natural competitive edge (the other three companies' indications are all paroxysmal atrial fibrillation, while persistent atrial fibrillation is still under clinical research for these three).
WithPulseSelectUpon listing, Medtronic has two star products in the electrophysiology market in China.PulseSelectAnd the Arctic Front series of cryoablation products. With these two powerful tools, Medtronic will engage in fierce competition with Johnson & Johnson, Boston Scientific, Abbott, and Hightech, among others. Who will emerge victorious remains to be seen.It is hoped that through fierce competition, more benefits can be brought to patients in China, while alleviating the pressure on the National Healthcare Security Administration.
PulseSelectIt is a new technology that utilizes pulsed electric fields to treat atrial fibrillation (AF), delivering bipolar, biphasic pulsed electric fields via a circular multi-electrode array catheter.PulseSelectConsists of five partsSteerable Multi-Electrode Circular Ablation Catheter、PFA Host、ECG-Gated、Tableside Control、10Fr Bidirectional Sheath。PulseSelectSteerable Multi-Electrode Circular Ablation CatheterWith proprietary biphasic waveform, unique built-in guidewire, and 20° forward tiltDesign, which can support the operability, reliability, and safety of the surgery.According to Medtronic, a single pulmonary vein isolation procedure,The average total energy delivery time was 30 seconds to isolate all veins. Isolation time and capability have beenPULSED AF has been confirmed in large-scale clinical trials.PulseSelectUsePulseRushElectric Field AblationOrCreate Damage and Scar Tissue，Interrupt Irregular Electrical Pathways in the HeartAnd atrial fibrillation triggers. However, unlike traditional ablation methods such as radiofrequency ablation or cryoablation,PulseSelectUsing non-thermal ablation methods, prioritizing cardiac tissue as the target,Selective targeting of cardiomyocytes, to avoid unnecessary damage to surrounding tissues and thus prevent complications associated with traditional ablation methods.
PulseSelect Demonstration
Medtronic is one of the largest medical technology, services, and solutions companies in the world, alleviating pain, restoring health, and extending life for millions of people globally. With over 90,000 employees worldwide, Medtronic serves doctors, hospitals, and patients in more than 150 countries. The company is committed to collaborating with stakeholders around the world to advance healthcare.
